Research programme: DNA vaccines - GeneOne

Drug Profile

Research programme: DNA vaccines - GeneOne

Alternative Names: GLS 5100

Latest Information Update: 15 Oct 2015

Price : $50

At a glance

  • Originator GeneOne Life Science
  • Class Varicella vaccines
  • Mechanism of Action Glycoprotein inhibitors; Immediate early protein inhibitors; Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Herpes zoster

Most Recent Events

  • 09 Oct 2015 Preclinical trials in Herpes zoster (Prevention) in South Korea (Parenteral) before October 2015
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top